CONGRESS ASSET MANAGEMENT CO

Position in AMRX — Amneal Pharmaceuticals, Inc.

CIK 897378 BOSTON, MA

Position in AMRX

as of Jun 30, 2026 · filed Jul 7, 2026 Compact

Position Value

$13,549,887

New position

Shares Held

782,778

first reported quarter

Ownership

0.245%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

#2

of 8 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 99.90546489553871.ToString("F0")% Shared 0.ToString("F0")% None 0.09453510446129043.ToString("F0")%

Healthcare · as of Jun 30, 2026

CONGRESS ASSET MANAGEMENT CO holds $29,146,248 across 3 Drug Manufacturers - Specialty & Generic names. AMRX ranks #2 (46.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	82,486	$13,902,190
2	AMRX	Amneal Pharmaceuticals, Inc. This page	782,778	$13,549,887
3	ZTS	Zoetis Inc.	23,576	$1,694,171

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$13,549,887	782,778	—	Shares	Sole	2026-07-07
No filing history on record for this holder in this stock.